Literature DB >> 33413395

The additive effects of kidney dysfunction on left ventricular function and strain in type 2 diabetes mellitus patients verified by cardiac magnetic resonance imaging.

Yi Zhang1, Jin Wang1, Yan Ren2, Wei-Feng Yan1, Li Jiang1, Yuan Li1, Zhi-Gang Yang3.   

Abstract

BACKGROUND: Patients with type 2 diabetes mellitus (T2DM) are susceptible to coexisted with chronic kidney disease (CKD), which may increase cardiovascular mortality in these patients. The present study aimed to verify whether CKD aggravates the deterioration of left ventricular (LV) myocardial strain in T2DM patients and to explore the risk factors associated with LV strain.
MATERIALS AND METHODS: In total, 105 T2DM patients and 52 healthy individuals were included and underwent cardiac magnetic resonance examination. Patients were divided into the following two groups: T2DM with CKD (n = 33) and T2DM without CKD (n = 72). The baseline clinical and biochemical indices were obtained from hospital records before the cardiac magnetic resonance scan. Cine sequences, including long-axis views (2-chamber and 4-chamber) and short-axis views, were acquired. LV function and global strain parameters were measured based on cine sequences and compared among three groups. Pearson's analysis was performed to investigate the correlation between LV strain parameters and clinical indices. Multiple linear regression analysis was used to identify the independent indicators of LV strain.
RESULTS: Compared with normal controls, T2DM patients without CKD had a significantly decreased magnitude of peak strain (PS; radial), peak systolic strain rate (radial), and peak diastolic strain rate (radial and circumferential) (all P < 0.05). Furthermore, T2DM patients with CKD displayed markedly lower magnitudes of PS (radial, circumferential, and longitudinal) and peak diastolic strain rate (circumferential and longitudinal) than both normal controls and T2DM patients without CKD (all P < 0.05). The eGFR was positively associated with the magnitude of PS (R = radial, 0.392; circumferential, 0.436; longitudinal, 0.556), while uric acid was negatively associated with the magnitude of PS (R = radial, - 0.361; circumferential, - 0.391; longitudinal, - 0.460) (all P < 0.001). Multivariable linear regression indicated that the magnitude of PS was independently associated with eGFR (β = radial, 0.314; circumferential, 0.292; longitudinal, 0.500) and uric acid (β = radial, - 0.239; circumferential, - 0.211; longitudinal, - 0.238) (all P < 0.05).
CONCLUSIONS: Kidney dysfunction may aggravate the deterioration of LV strain in T2DM patients. LV strain is positively associated with the estimated glomerular filtration rate and negatively associated with uric acid, which may be independent risk factors for predicting reduction of LV strain.

Entities:  

Keywords:  Chronic kidney disease; Left ventricular; Magnetic resonance imaging; Strain; Type 2 diabetes mellitus

Year:  2021        PMID: 33413395      PMCID: PMC7792094          DOI: 10.1186/s12933-020-01203-4

Source DB:  PubMed          Journal:  Cardiovasc Diabetol        ISSN: 1475-2840            Impact factor:   9.951


  29 in total

1.  Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes.

Authors:  James J Chamberlain; Andrew S Rhinehart; Charles F Shaefer; Annie Neuman
Journal:  Ann Intern Med       Date:  2016-03-01       Impact factor: 25.391

2.  IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.

Authors:  N H Cho; J E Shaw; S Karuranga; Y Huang; J D da Rocha Fernandes; A W Ohlrogge; B Malanda
Journal:  Diabetes Res Clin Pract       Date:  2018-02-26       Impact factor: 5.602

3.  Three-dimensional assessment of left ventricular systolic strain in patients with type 2 diabetes mellitus, diastolic dysfunction, and normal ejection fraction.

Authors:  Carissa G Fonseca; Ajith M Dissanayake; Robert N Doughty; Gillian A Whalley; Greg D Gamble; Brett R Cowan; Christopher J Occleshaw; Alistair A Young
Journal:  Am J Cardiol       Date:  2004-12-01       Impact factor: 2.778

4.  The combined effects of cardiac geometry, microcirculation, and tissue characteristics on cardiac systolic and diastolic function in subclinical diabetes mellitus-related cardiomyopathy.

Authors:  Li Jiang; Jin Wang; Xi Liu; Zhen-Lin Li; Chun-Chao Xia; Lin-Jun Xie; Yue Gao; Meng-Ting Shen; Pei-Lun Han; Ying-Kun Guo; Zhi-Gang Yang
Journal:  Int J Cardiol       Date:  2020-07-15       Impact factor: 4.164

5.  Prognostic Value of Strain by Tissue Tracking Cardiac Magnetic Resonance After ST-Segment Elevation Myocardial Infarction.

Authors:  Jose Gavara; Jose F Rodriguez-Palomares; Filipa Valente; Jose V Monmeneu; Maria P Lopez-Lereu; Clara Bonanad; Ignacio Ferreira-Gonzalez; Bruno Garcia Del Blanco; Julian Rodriguez-Garcia; Maria Mutuberria; Elena de Dios; Cesar Rios-Navarro; Nerea Perez-Sole; Paolo Racugno; Ana Paya; Gema Minana; Joaquim Canoves; Mauricio Pellicer; Francisco J Lopez-Fornas; Jose Barrabes; Arturo Evangelista; Julio Nunez; Francisco J Chorro; David Garcia-Dorado; Vicente Bodi
Journal:  JACC Cardiovasc Imaging       Date:  2017-12-13

Review 6.  Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease.

Authors:  Merlin C Thomas; Mark E Cooper; Paul Zimmet
Journal:  Nat Rev Nephrol       Date:  2015-11-10       Impact factor: 28.314

Review 7.  Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update : Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on Standardized Post-Processing.

Authors:  Jeanette Schulz-Menger; David A Bluemke; Jens Bremerich; Scott D Flamm; Mark A Fogel; Matthias G Friedrich; Raymond J Kim; Florian von Knobelsdorff-Brenkenhoff; Christopher M Kramer; Dudley J Pennell; Sven Plein; Eike Nagel
Journal:  J Cardiovasc Magn Reson       Date:  2020-03-12       Impact factor: 5.364

8.  Characterisation of cardiomyopathy by cardiac and aortic magnetic resonance in patients new to hemodialysis.

Authors:  Aghogho Odudu; Mohamed Tarek Eldehni; Gerry P McCann; Mark A Horsfield; Tobias Breidthardt; Christopher W McIntyre
Journal:  Eur Radiol       Date:  2015-12-17       Impact factor: 5.315

9.  Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate.

Authors:  Kunihiro Matsushita; Bakhtawar K Mahmoodi; Mark Woodward; Jonathan R Emberson; Tazeen H Jafar; Sun Ha Jee; Kevan R Polkinghorne; Anoop Shankar; David H Smith; Marcello Tonelli; David G Warnock; Chi-Pang Wen; Josef Coresh; Ron T Gansevoort; Brenda R Hemmelgarn; Andrew S Levey
Journal:  JAMA       Date:  2012-05-09       Impact factor: 56.272

View more
  4 in total

1.  A synergistic effect of variability in estimated glomerular filtration rate with chronic kidney disease on all-cause mortality prediction in patients with type 2 diabetes: a retrospective cohort study.

Authors:  Yu-Shan Chang; Yu-Hsuan Li; I-Te Lee
Journal:  Cardiovasc Diabetol       Date:  2021-10-18       Impact factor: 9.951

2.  Additive Effects of Obesity on Myocardial Microcirculation and Left Ventricular Deformation in Essential Hypertension: A Contrast-Enhanced Cardiac Magnetic Resonance Imaging Study.

Authors:  Pei-Lun Han; Xue-Ming Li; Li Jiang; Wei-Feng Yan; Ying-Kun Guo; Yuan Li; Kang Li; Zhi-Gang Yang
Journal:  Front Cardiovasc Med       Date:  2022-03-24

3.  Effect of Tegretol on Oxidative Stress, Serum Inflammatory Factors, and Left Ventricular Function in AMI Patients after Emergency PCI.

Authors:  Liping Ma; Yizhan Pan; Ziying Wu; Lin Zhang; Zhaojin Feng; Ketao Li
Journal:  Comput Math Methods Med       Date:  2022-08-02       Impact factor: 2.809

4.  Additive effect of aortic regurgitation degree on left ventricular strain in patients with type 2 diabetes mellitus evaluated via cardiac magnetic resonance tissue tracking.

Authors:  Li-Ting Shen; Li Jiang; Ya-Wen Zhu; Meng-Ting Shen; Shan Huang; Rui Shi; Yuan Li; Zhi-Gang Yang
Journal:  Cardiovasc Diabetol       Date:  2022-03-11       Impact factor: 9.951

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.